Brands

Funding & Finance

Evotec Appoints Dr Ingrid Müller as Chief Operating Officer

Evotec has announced the appointment of Dr Ingrid Müller as Chief Operating Officer (COO). Dr Müller will be joining Evotec’s Management Board, effective 1...

Drug Discovery & Development

Renaissance Pharma secures FDA Fast Track Designation and IND clearance for Daretabart in high-risk neuroblastoma

The US Food and Drug Administration (FDA) has granted Fast Track Designation for Daretabart (hu1418K322A), a novel anti-GD2 monoclonal antibody in development for the...

Clinical Trials Insights

AbbVie’s Elahere succeeds in phase 2 platinum-sensitive ovarian cancer trial

AbbVie has announced that late-breaking results from the phase 2 IMGN853-0420 trial. The study evaluated the potential efficacy and safety of mirvetuximab soravtansine-gynx, a first-in-class antibody-drug...

Pharma in Healthcare

Cell line development market to reach $8.95 billion by 2031 with Gene & Cell Therapy manufacturing growing at 10.88%

According to Mordor Intelligence, the global cell line development market is projected to grow from USD 4.97 billion in 2025 to USD 5.48 billion in 2026, and is expected to...

Events and Conferences

Global Drug Delivery and Formulation (DDF) Summit

18-20 May Berlin, Germany The Global Drug Delivery and Formulation (DDF) Summit is Europe’s premier gathering for professionals at the forefront of pharmaceutical development and drug delivery...

Events and Conferences

Chemspec Europe reveals new details about 2026 conference programme

6–7 May 2026 Koln, Germany Chemspec Europe has unveiled further details of its highly anticipated conference programme, offering attendees fresh insight into the key...

Drug Discovery & Development

Oragenics doses first patient in phase 2a clinical trial of drug for mild traumatic brain injury

Oragenics, a clinical-stage biotechnology company developing brain-targeted therapeutics through proprietary intranasal delivery technology, has announced that the first patient has been dosed in its...

Drug Discovery & Development

Bracco invests in GMP manufacturing facility for cell therapy products

Bracco Imaging, a global pharmaceutical company that develops, manufactures, and markets innovative healthcare solutions, announced an upgrade of its manufacturing site in Geneva to...

- Advertisement -

Latest stories

Funding & Finance